Clinical Updates
Drug approvals, guideline changes, and treatment advances
Neurotensin Receptor 2 Activation Shows Promise in Preventing Heart Failure Progression
Activation of neurotensin receptor 2 in preclinical models significantly reduced pathological changes in heart tissue, suggesting a novel therapeutic target…
Editor's Top Picks
Innate Immune Strength Paradoxically Linked to Worse Flu Symptoms in Controlled Challenge Study
A controlled human influenza challenge study in Nature Medicine reveals that heightened innate immune cell responsiveness paradoxically correlates with increased…
Submit Your Paper →
More form Clinical Updates
Diabetic Foot Ulcer in a 67-Year-Old Man: Clinical Case and Management Lessons
A 67-year-old man with type 2 diabetes presented with a chronic foot ulcer, illustrating the…
Foamy immune cells packed with fat may drive MS progression, new brain tissue study suggests
Researchers have discovered that immune cells packed with lipid droplets accumulate in the brains of…
Kwashiorkor: How Severe Protein Deficiency Disrupts Child Development
A clinical case in the New England Journal of Medicine highlights how severe protein deficiency…
Early immune markers could identify which TB-infected people will develop active disease
Research at the Francis Crick Institute suggests that specific immune markers may predict which of…
Novel Prime-and-Pull Vaccine Strategy Shows Promise Against Genital Herpes in Preclinical Models
Yale researchers developed a novel prime-and-pull vaccine that prevented genital herpes infection in preclinical models,…

